Patients typically receive semaglutide as a once-weekly injection , which makes it convenient but also requires understanding how the body may react soon after administration
Research has investigated its role in sleep-wake cycle regulation, pituitary hormone secretion, stress adaptation, and nociceptive pathways
Glucagon-like peptide 1 (GLP-1) acts as an incretin hormone and anorexigenic neuropeptide, prompting the successful and ongoing development of GLP-1-based therapies for type 2 diabetes and obesity 1,2
It effectively manages blood sugar levels, making it invaluable for individuals with type 2 diabetes
In rare cases, semaglutide may be linked with Gallbladder problems, kidney injury, Pancreatitis, or worsening Diabetic Retinopathy
PMID: 39060389 Acta Pharm Sin B 2021 Dec;11(12):4045-4054